EA199800023A1 - Фармацевтическая композиция, содержащая ингибитор протеиназы и моноглицерид - Google Patents
Фармацевтическая композиция, содержащая ингибитор протеиназы и моноглицеридInfo
- Publication number
- EA199800023A1 EA199800023A1 EA199800023A EA199800023A EA199800023A1 EA 199800023 A1 EA199800023 A1 EA 199800023A1 EA 199800023 A EA199800023 A EA 199800023A EA 199800023 A EA199800023 A EA 199800023A EA 199800023 A1 EA199800023 A1 EA 199800023A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- monoglycerides
- pharmaceutical composition
- composition containing
- proteinase inhibitor
- containing proteinase
- Prior art date
Links
- 239000000137 peptide hydrolase inhibitor Substances 0.000 title abstract 2
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical compound CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 2
- 229940019748 antifibrinolytic proteinase inhibitors Drugs 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- -1 medium chain fatty acid monoglycerides Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
В заявке описаны композиции, увеличивающие биологическую доступность ингибиторов протеиназы. Композиции содержат фармацевтически приемлемый носитель, включающий моноглицериды жирных кислот со средней длиной цепи.Международная заявка была опубликована вместе с отчетом о международном поиске.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US46849395A | 1995-06-06 | 1995-06-06 | |
US08/616,233 US6008228A (en) | 1995-06-06 | 1996-05-07 | Pharmaceutical compositions containing proteinase inhibitors |
PCT/EP1996/002431 WO1996039142A1 (en) | 1995-06-06 | 1996-06-04 | Pharmaceutical composition comprising a proteinase inhibitor and a monoglyceride |
Publications (2)
Publication Number | Publication Date |
---|---|
EA199800023A1 true EA199800023A1 (ru) | 1998-08-27 |
EA001413B1 EA001413B1 (ru) | 2001-02-26 |
Family
ID=27042422
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA199800023A EA001413B1 (ru) | 1995-06-06 | 1996-06-04 | Фармацевтическая композиция, содержащая ингибитор протеиназы и моноглицерид |
Country Status (27)
Country | Link |
---|---|
EP (1) | EP0831826B1 (ru) |
JP (1) | JP3238412B2 (ru) |
CN (1) | CN1092960C (ru) |
AT (1) | ATE226075T1 (ru) |
AU (1) | AU709796B2 (ru) |
BG (1) | BG63711B1 (ru) |
BR (1) | BR9610842A (ru) |
CA (1) | CA2224125C (ru) |
CY (1) | CY2373B1 (ru) |
CZ (1) | CZ292192B6 (ru) |
DE (1) | DE69624354T2 (ru) |
DK (1) | DK0831826T3 (ru) |
EA (1) | EA001413B1 (ru) |
ES (1) | ES2182996T3 (ru) |
HK (1) | HK1010136A1 (ru) |
HU (1) | HU223899B1 (ru) |
IL (1) | IL122353A0 (ru) |
IS (1) | IS2661B (ru) |
MX (1) | MX9709193A (ru) |
NO (1) | NO324531B1 (ru) |
NZ (1) | NZ311646A (ru) |
OA (1) | OA10546A (ru) |
PL (1) | PL184820B1 (ru) |
PT (1) | PT831826E (ru) |
SK (1) | SK282121B6 (ru) |
TR (1) | TR199701541T1 (ru) |
WO (1) | WO1996039142A1 (ru) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR9810729B1 (pt) | 1997-07-29 | 2010-07-13 | composição farmacêutica para compostos lipofìlicos ácidos disposta como uma formulação auto-emulsificante. | |
NZ502567A (en) | 1997-07-29 | 2002-03-28 | Upjohn Co | Self-emulsifying formulation for lipophilic compounds containing a pyranone and a mixture of monoglycerides and diglycerides |
US7258869B1 (en) | 1999-02-08 | 2007-08-21 | Alza Corporation | Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle |
KR20080045300A (ko) * | 1999-02-08 | 2008-05-22 | 알자 코포레이션 | 안정한 비수성 단일상 점성 비히클 및 그 비히클을이용하는 제형물 |
US7919109B2 (en) | 1999-02-08 | 2011-04-05 | Intarcia Therapeutics, Inc. | Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles |
US6956048B2 (en) | 1999-03-31 | 2005-10-18 | Pharmacia & Upjohn Company | Pharmaceutical emulsions for retroviral protease inhibitors |
US6309663B1 (en) * | 1999-08-17 | 2001-10-30 | Lipocine Inc. | Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents |
BR0202252A (pt) | 2002-06-12 | 2004-06-29 | Cristalia Prod Quimicos Farm | Composição farmacêutica solúvel estável para administração de inibidores da hiv protease e processo de obtenção de composições farmacêuticas concentradas para a administração de inibidores da hiv protease |
US7731947B2 (en) | 2003-11-17 | 2010-06-08 | Intarcia Therapeutics, Inc. | Composition and dosage form comprising an interferon particle formulation and suspending vehicle |
US11246913B2 (en) | 2005-02-03 | 2022-02-15 | Intarcia Therapeutics, Inc. | Suspension formulation comprising an insulinotropic peptide |
WO2006083761A2 (en) | 2005-02-03 | 2006-08-10 | Alza Corporation | Solvent/polymer solutions as suspension vehicles |
DE602007009377D1 (de) | 2006-05-30 | 2010-11-04 | Intarcia Therapeutics Inc | Zweiteiliger flussmodulator mit einem internen kanal für ein osmotisches ausgabesystem |
WO2008133908A2 (en) | 2007-04-23 | 2008-11-06 | Intarcia Therapeutics, Inc. | Suspension formulations of insulinotropic peptides and uses thereof |
DK2240155T3 (da) | 2008-02-13 | 2012-09-17 | Intarcia Therapeutics Inc | Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler |
EP2108705A1 (en) | 2008-04-08 | 2009-10-14 | Universität Duisburg-Essen | Method for analysing the epigenetic status of the HtrA 1 gene in a biological sample |
MX352878B (es) | 2009-09-28 | 2017-12-13 | Intarcia Therapeutics Inc | Establecimiento y/o terminacion rapidos de suministro de estado estable sustancial de farmaco. |
US20120208755A1 (en) | 2011-02-16 | 2012-08-16 | Intarcia Therapeutics, Inc. | Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers |
US9889085B1 (en) | 2014-09-30 | 2018-02-13 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
EP4278996A3 (en) | 2015-06-03 | 2024-01-24 | i2o Therapeutics, Inc. | Implant placement systems |
EP3458084B1 (en) | 2016-05-16 | 2020-04-01 | Intarcia Therapeutics, Inc | Glucagon-receptor selective polypeptides and methods of use thereof |
USD840030S1 (en) | 2016-06-02 | 2019-02-05 | Intarcia Therapeutics, Inc. | Implant placement guide |
USD860451S1 (en) | 2016-06-02 | 2019-09-17 | Intarcia Therapeutics, Inc. | Implant removal tool |
MX2019008006A (es) | 2017-01-03 | 2019-08-29 | Intarcia Therapeutics Inc | Metodos que comprenden la administracion continua de un agonista del receptor de glp-1 y la co-administracion de un farmaco. |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8927913D0 (en) * | 1989-12-11 | 1990-02-14 | Hoffmann La Roche | Amino acid derivatives |
IL110752A (en) * | 1993-09-13 | 2000-07-26 | Abbott Lab | Liquid semi-solid or solid pharmaceutical composition for an HIV protease inhibitor |
-
1996
- 1996-06-04 TR TR97/01541T patent/TR199701541T1/xx unknown
- 1996-06-04 EP EP96921929A patent/EP0831826B1/en not_active Expired - Lifetime
- 1996-06-04 MX MX9709193A patent/MX9709193A/es unknown
- 1996-06-04 NZ NZ311646A patent/NZ311646A/en not_active IP Right Cessation
- 1996-06-04 AT AT96921929T patent/ATE226075T1/de active
- 1996-06-04 JP JP50014397A patent/JP3238412B2/ja not_active Expired - Lifetime
- 1996-06-04 BR BR9610842A patent/BR9610842A/pt not_active IP Right Cessation
- 1996-06-04 EA EA199800023A patent/EA001413B1/ru not_active IP Right Cessation
- 1996-06-04 IL IL12235396A patent/IL122353A0/xx not_active IP Right Cessation
- 1996-06-04 CA CA002224125A patent/CA2224125C/en not_active Expired - Lifetime
- 1996-06-04 DK DK96921929T patent/DK0831826T3/da active
- 1996-06-04 CZ CZ19973803A patent/CZ292192B6/cs not_active IP Right Cessation
- 1996-06-04 SK SK1627-97A patent/SK282121B6/sk not_active IP Right Cessation
- 1996-06-04 CN CN96194327A patent/CN1092960C/zh not_active Expired - Lifetime
- 1996-06-04 HU HU9801905A patent/HU223899B1/hu active IP Right Grant
- 1996-06-04 DE DE69624354T patent/DE69624354T2/de not_active Expired - Lifetime
- 1996-06-04 ES ES96921929T patent/ES2182996T3/es not_active Expired - Lifetime
- 1996-06-04 WO PCT/EP1996/002431 patent/WO1996039142A1/en active IP Right Grant
- 1996-06-04 AU AU63004/96A patent/AU709796B2/en not_active Expired
- 1996-06-04 PL PL96323860A patent/PL184820B1/pl unknown
- 1996-06-04 PT PT96921929T patent/PT831826E/pt unknown
-
1997
- 1997-12-04 IS IS4627A patent/IS2661B/is unknown
- 1997-12-05 BG BG102106A patent/BG63711B1/bg unknown
- 1997-12-05 OA OA70151A patent/OA10546A/en unknown
- 1997-12-05 NO NO19975665A patent/NO324531B1/no not_active IP Right Cessation
-
1998
- 1998-09-09 HK HK98110542A patent/HK1010136A1/xx not_active IP Right Cessation
-
2003
- 2003-08-22 CY CY0300057A patent/CY2373B1/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA199800023A1 (ru) | Фармацевтическая композиция, содержащая ингибитор протеиназы и моноглицерид | |
TR200200129T2 (tr) | Hepatit C inhibitörü tri-peptidler | |
EA200000768A1 (ru) | ЗАМЕЩЕННЫЕ ОКСОАЗАГЕТЕРОЦИКЛИЧЕСКИЕ ИНГИБИТОРЫ ФАКТОРА Ха | |
TR200100472T2 (tr) | Lipaz inhibitörleri ile sitozan içeren farmasötik bileşimler | |
ID18142A (id) | Inhibitor metaloprotease 1,4-heterosiklik | |
GEP20012388B (en) | Metalloproteinase Inhibitors, Pharmaceutical Compositions on Their Base, Use and Methods for Obtaining and Intermediates | |
KR950700323A (ko) | 엔케팔리나제 및 안지오텐신 전환 효소의 억제제로서 유용한 아미노아세틸머캅토아세틸아미드 유도체(Aminoacetylmercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ACE) | |
DE69434214D1 (de) | HIV protease inhibitoren | |
EP0677048A1 (en) | CYCLIC SULPHONES AS INHIBITORS RETROVIRAL PROTEASES. | |
EA200001236A1 (ru) | НОВЫЕ ИНГИБИТОРЫ VLA-4:oMePUPA-V | |
UY24248A1 (es) | Composiciones farmacéuticas que contienen inhibidores de proteinasa | |
DK0937036T3 (da) | Substituerede 4-biphenyl-4-hydroxysmørsyrederivater som matrixmetalprotease-inhibitorer | |
EA199900809A1 (ru) | Производные 2-(замещенный бензоил) циклоакил-1-карбоновой кислоты | |
CO5070670A1 (es) | Taloproteinasas de arilsulfonamidas y estatinas | |
ECSP961778A (es) | Composiciones que incrementan la biodisponibilidad de inhibidores de proteinasa | |
MX9204528A (es) | 0etodo para tratar el sindrome premenstrual mediante administracion de un inhibidor de la enzima de conversion de angiotensina. | |
NO965353D0 (no) | 3-amino-2-okso-1-piperidineddiksyrederivater som enzyminhibitorer | |
ZA93857B (en) | Novel aminoacetylmercapto derivatives useful as inhibitors of enkephalinase and ACE. | |
ZA922501B (en) | Thid-carboxylic acid derivatives as collagenase inhibitors. | |
TNSN96081A1 (fr) | Composition antiretrovirale |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM MD |
|
MK4A | Patent expired |
Designated state(s): AZ BY KZ KG TJ TM RU |